Irodalom:
1. Swisher SG, Hofstetter W, Wu TT, et al: Proposed revision of the eosphageal cancer staging system to
accommodate pathologic response (pP) following preopertive chemoradiation (CRT).
Ann Surg 241:810-820, 2005
2. Rizk NP, Venkatraman E, Bains MS, et al: American Joint Committee on cancer staging system does
not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma.
J Clin Oncol 25:507-512, 2007
A nyelõcsõ 89
3. Kan T, Shimada Y, Sato F, et al: Prediction of lymph node metastasis with use of artificial neural network
based on gene expression profiles in esophageal squamous cell carcinoma. Am Surg Oncol 11:1070-
1078, 2004
4. Kan T, Shimada Y, Sato F, et al: Gene expression profiling in human esophageal cancers using cDNA
microarray. Biochem Biophys Res Commun 286:792-801, 2001
5. Guo Y, Chen Z, Zhang L, et al: Distinctive microRNA profiles relating to patient survival in esophageal
squamous cell carcinoma. Cancer Res 68:26-34, 2008
6. Sunpaweravong P, Sunpaweravong S, Puttawibul P, et al: Epidermal growth factor receptor and cyclin
D1 are independently amplified and overexpressed in esophageal squamous cell carcinoma. J Cancer
Res Clin Oncol 131:111-119, 2005
7. Gibault L, Metges J-P, Conan-Charlet V, et al: Diffuse EGFR staining is associated with reduced overall
survival in locally advanced oesophageal squamous cell cancer. Br J Cancer 93:107-115, 2005
8. Fukai Y, Masuda N, Kato H, et al: Correlation between laminin-5 gamma2 chain and epidermal growth
factor receptor expression in esophageal squamous cell carcinomas. Oncology 69:71-80, 2005
9. Ekmar S, Bergqvist M, Heldin CH, Lennartsson J.: Activation of growth factor receptors in esophageal
cancer – Implications for therapy. The Oncologist 12:1165-1177, 2007
10. Xu S, Kitayama J, Yamashita H, et al: Nuclear translocation of HER-4/c-erbB-4 is significantly correlated
with prognosis of esophageal squamous cell carcinoma. J Surg Oncol 97:44-50, 2007
11. Yoshinaga K, Inoue H, Utsunomiya T, et al: N-cadherin is regulated by activin A and associated with
tumor aggressiveness in esophageal carcinoma. Clin Cancer Res 10:5702-5707, 2004
12. Yamazaki K, Masegawa M, Ohaka I, et al: Increased E2F-2 expression via tumour cell proliferation
and decreased apoptosis are correlated with adverse prognosis in patients with squamous cell carcinoma
of the oesophagus. J Clin Pathol 58:904-910
13. Mega S, Miyamoto M, Ebihara Y, et al: Cyclin D1, E2F1 expression levels are associated with characteristics
and prognosis of esophageal squamous cell carcinoma. Dis Esophagjus 18:109-113, 2005
14. Chang MS, Lee HS, Lee BL, et al: Differential protein expression between esophageal squamous cell
carcinoma and dysplasia, and prognostic significance of protein markers. Pathol Res Pract 201:417-
425, 2005
15. Zhou J, Zhao LQ, Xiong MM et al: Gene expression profiles at different stages of human esophageal
squamous cell carcinoma. World J Gastroenterol 9:9-15,2005.
16. Shimada Y, Watanabe G, Kawamura J, et al: Clinical signigicance of osteopontin in esophageal squamous
cell carcinoma: comparison with common tumor markers. Ocology 68:285-292, 2005
17. Mori Y, Ishiguro H, Kuwabara Y, et al: Expression of ECRG4 is an independent prognostic factor for
poor survival in patients with esophageal squamous cell carcinoma. Oncol Rep 18:981-985, 2007
18. Ding XW, Luo HS, Luo B, et al: Overexpression of hERG1 in resected esophageal squamous cell
carcinomas: A marker for poor prognosis. J Surg Oncol 97:57-62, 2007
19. Hoshino I, Matsubara H, Akutsu Y, et al: Tumor suppressor Prdx1 is a prognostic factor in esophageal
squamous cell carcinoma patients. Oncol Rep 18:867-871, 2007
20. Lukits J, Remenár É, Rásó E, et al: Molecular identification, expression and prognostic role of estrogenand
progesterone receptors in head and neck cancer. Int J Oncol 30:155-160, 2007
21. Nozoe T, Oyama T, Takenoyama M, et al: Significance of immunohistochemical expression of estrogen
receptor a and b in squamous cell carcinoma of the esophagus. Clin Cancer Res 13:4046, 2007
22. Ren Y, Cao B, Law S, et al: Hepatocyte growth factor promotes cancer cell migration and angiogenic
90 Gastro Update 2008
factors expression: a prognostic marker of human esophageal squamous cell carcinomas. Clin Cancer
Res 11:6190-6197, 2005
23. Kase S, Osaki M, Honjo S, et al: Expression of cyclo-oxygenase-2 is correlated with high intratumoral
micovessel density and low apoptotic index in human esophageal squamous cell carcinomas. Virchows
Arch 442:129-135, 2003
24. Kumagai Y, Masakazu T, Inoue H.: Dynamism of tumour vasculature in the early phase of cancer
progression: outcomes from oesophageal cancer research. Lancet Oncol 3:604-610, 2002
25. Kimura S, Kitadai Y, Kuwai T, et al: Expression of p53 protein in esophageal squamous cell carcinoma:
relation to hypoxia-inducible factor-1 alpha, angiogenesis and apoptosis. Pathobiology 72:179-185, 2005
26. Matsuyama T, Nakanishi K, Hayashi T, et al: Expression of hypoxia-inducible factor-1a in esophageal
squamous cell carcinoma. Cancer Sci 96:176-182, 2005
27. Kimura S, Kitadai Y, Kuwai T, et al: Expression of p53 protein in esophagel squamous cell carcinoma:
relation to hypoxia-inducible factor-1 alpha, angiogenesis and apoptosis. Pathobiology 72:179-185, 2005
28. Kleespies A, Bruns CJ, Januch KW.: Clinical significance of VEGF-A, -C and -D expression in
esophageal malignancies. Onkologie 28:281-288, 2005
29. Mukherjee T, Kumar A, Mathur M, et al: Ets-1 and VEGF expression correlates with tumor angiogenesis,
lymph node metastasis, and patient survival in esophageal squamous cell carcinoma. J Cancer Res Clin
Oncol 129:430-436, 2003
30. Nakamura T, Ozawa S, Kitagawa Y, et al: Expression of basic fibroblast growth factor is associated
with a good outcome in patients with squamous cell carcinoma of the esophagus. Oncol Rep 14:617-
623, 2005
31. Kato H, Nakajima M, Masuda N, Faried A, Sohda M, Fukai Y, Miyazaki T, Fukuchi M Tsukada K,
Kuwano H.: Expression of RCAS1 in esopshageal squamous cell carcinoma is associated with a poor
prognosis. J Surg Oncol 90:89-94, 2005
32. Ishikawa N, Takano A, Yasui W, et al: Cancer-testis antigen lymphocyte antigen 6 complex locus K is
a serologic biomarker and a therapeutic target for lung and esophageal carcinoma. Cancer Res
67:11601-11611, 2007
33. Guo SJ, Lin DM, Li J, et al: Tumor-associated macrophages and CD3-zeta expression of tumor-infiltrating
lymphocytes in human esophageal squamous-cell carcinoma. Dis Esophagus 20:107-116, 2007
34. Krzystek-Korpacka M, Matusiewicz M, Diakowska D, et al: Serum midkine depends on lymph node
involvement and correlates with circulating VEGF-C in oesophageal squamous cell carcinoma. Biomarkers
12:304-413, 2007
35. Kihara C, Tsunoda T, Tanaka T, et al: Prediction of sensitivity of esophageal tumors to adjuvant
chemotherapy by cDNA microarray analysis of gene-expression profiles. Cancer Res 61:6474-6479, 2001
36. Toshimitsu H, Hashimoto K, Tangoku A, et al: Molecular signature linked to acquired resistance to cisplatin
in esophageal cancer cells. Cancer Letters 211:69-78, 2004
37. Tsunoda S, Okumura T, Ito T, et al: ABCG2 expression is an independent unfavorable prognostic factor
in esophageal squamous cell carcinoma. Oncology 71:251-258, 2006
38. Sakakura C, Miyagawa K, Fukuda KI, et al: Frequent silencing of RUNX3 in esophageal squamous
cell carcinoma is associated with radioresistance and poor prognosis. Oncogene 26:5927-5938, 2007
39. Miyazono F, Metzger R, Wernecke-Eberz U, et al: Quantitative c-erbB-2 but not c-erbB-1 mRNA
expression is a promising marker to predict minor histopathologic response to neoadjuvant
radiochemotherapy in oesophageal cancer. Br J Cancer 91:666-672, 2004
A nyelõcsõ 91
40. Gotoh M, Takiuchi H, Kawabe S, et al: Epidermal growth factor receptor is a possible predictor of
sensitivity to chemoradiotherapy in the primary lesion of esophageal squamous cell carcinoma. Jpn J
Clin Oncol 37:652-657, 2007
